BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11024386)

  • 1. Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients.
    Oei FB; Welters MJ; Knoop CJ; Vaessen LM; Stegmann AP; Weimar W; Bogers AJ
    Eur J Cardiothorac Surg; 2000 Oct; 18(4):466-72. PubMed ID: 11024386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cytotoxic T lymphocytes with destructive potential after cardiac valve homograft implantation.
    Oei FBS ; Welters MJ; Vaessen LM; Stegmann AP; Bogers AJ; Weimar W
    J Heart Valve Dis; 2000 Nov; 9(6):761-8. PubMed ID: 11128781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of circulating cytotoxic T lymphocyte precursors that have a high avidity for donor antigens: correlation with the rejection status of the human cardiac allograft.
    van Emmerik NE; Vaessen LM; Knoop CJ; Daane CR; Balk AH; Mochtar B; Claas FH; Weimar W
    Transpl Immunol; 1998 Sep; 6(3):153-60. PubMed ID: 9848221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation.
    Mathew JM; Marsh JW; Susskind B; Mohanakumar T
    J Clin Invest; 1993 Mar; 91(3):900-6. PubMed ID: 8450068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific hyporeactivity after liver transplantation: prominent decreases in donor-specific cytotoxic T lymphocyte precursor frequencies independent of changes in helper T lymphocyte precursor frequencies or suppressor cell activity.
    de Haan A; van den Berg AP; Hepkema BG; van Dijk E; Haagsma EB; The TH; Slooff MJ; Lems SP; de Leij LF; Prop J
    Transplantation; 1998 Aug; 66(4):516-22. PubMed ID: 9734497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency analysis of donor-reactive cytotoxic T lymphocyte precursors in in allograft recipients. Lack of correlation with clinical outcome.
    Eberspächer ML; Otto G; Herfarth C; Kabelitz D
    Transplantation; 1994 Jun; 57(12):1746-52. PubMed ID: 8016880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT.
    Speiser DE; Löliger CC; Siren MK; Jeannet M
    Br J Haematol; 1996 Jun; 93(4):935-9. PubMed ID: 8703829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts.
    Welters MJ; Oei FB; Witvliet MD; Vaessen LM; Cromme-Dijkhuis AH; Bogers AJ; Weimar W; Claas FH
    Hum Immunol; 2002 Nov; 63(11):1019-25. PubMed ID: 12392854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejection.
    van Emmerik NE; Vaessen LM; Balk AH; Bos E; Claas FH; Weimar W
    Transplantation; 1996 Aug; 62(4):529-36. PubMed ID: 8781621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child.
    van Kampen CA; Versteeg-vd Voort Maarschalk MF; Langerak-Langerak J; Roelen DL; Claas FH
    Hum Immunol; 2002 Jun; 63(6):452-8. PubMed ID: 12039520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased donor-specific cytotoxic T cell precursor frequencies one year after clinical lung transplantation do not reflect transplantation tolerance: a comparison of lung transplant recipients with or without bronchiolitis obliterans syndrome.
    de Haan A; van der Gun I; Hepkema BG; de Boer WJ; van der Bij W; de Leij LF; Prop J
    Transplantation; 2000 Apr; 69(7):1434-9. PubMed ID: 10798767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of donor-specific cytotoxic T lymphocyte precursors after transfusion.
    Vandekerckhove BA; van Bree S; Zhang L; Datema G; Zantvoort F; Claas FH
    Transplantation; 1989 Oct; 48(4):672-5. PubMed ID: 2799922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of donor-specific cytotoxic T lymphocyte precursors in peripheral blood of allografted heart recipients.
    Hu H; Robertus M; de Jonge N; Gmelig-Meyling FH; van der Meulen A; Schuurman HJ; Doornewaard H; van Prooijen HC; de Weger RA
    Transplantation; 1994 Dec; 58(11):1263-8. PubMed ID: 7992372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The avidity, not the mere presence, of primed cytotoxic T-lymphocytes for donor human leukocyte class II antigens determines their clinical relevance after heart transplantation.
    van Emmerik NE; Loonen EH; Vaessen LM; Balk AH; Mochtar B; Claas FH; Weimar W
    J Heart Lung Transplant; 1997 Feb; 16(2):240-9. PubMed ID: 9059936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency and avidity of committed cytotoxic T lymphocytes (cCTL) for donor HLA class I and class II antigens and their relation with graft vascular disease.
    van Besouw NM; Loonen EH; Vaessen LM; Balk AH; Claas FH; Weimar W
    Clin Exp Immunol; 1998 Mar; 111(3):548-54. PubMed ID: 9528897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD.
    de Bueger M; Bakker A; Bontkes H; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1993 May; 11(5):363-8. PubMed ID: 8504270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation.
    Kircher B; Niederwieser D; Gächter A; Lätzer K; Eibl G; Gastl G; Nachbaur D
    Ann Hematol; 2004 Sep; 83(9):566-72. PubMed ID: 15170521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data.
    Roelen DL; Stobbe I; Young NT; van Bree SP; Doxiadis II; Oudshoorn M; Morris PJ; Wood KJ; Claas FH
    Hum Immunol; 2001 Jul; 62(7):661-7. PubMed ID: 11423171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.